Meeder Asset Management Inc Esperion Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$30.04 - $51.31 $17,423 - $29,759	-580 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$27.44 - $73.84 $15,915 - $42,827	580 New	580 $18,000
Q1 2019 Apr 16, 2019	SELL	$40.11 - $53.57 $3,930 - $5,249	-98 Closed	0 $0
Q4 2018 Jan 17, 2019	BUY	$36.99 - $59.11 $3,625 - $5,792	98 New	98 $5,000
Q2 2018 Jul 24, 2018	SELL	$36.2 - $76.4 $14,624 - $30,865	-404 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$65.94 - $80.76 $2,176 - $2,665	33 Added 8.89%	404 $30,000
Q4 2017 Feb 02, 2018	BUY	$43.47 - $67.43 $4,955 - $7,687	114 Added 44.36%	371 $25,000
Q3 2017 Oct 20, 2017	BUY	$43.8 - $52.77 $11,256 - $13,561	257	257 $13,000

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $155M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.